{"id":16578,"date":"2026-09-10T15:30:00","date_gmt":"2026-09-10T06:30:00","guid":{"rendered":"https:\/\/microncro.com\/archives\/post\/strategic-collaboration-with-adjutor-group-strengthening-support-capabilities-across-japan-australia-and-new-zealand-copy\/"},"modified":"2026-09-10T17:00:27","modified_gmt":"2026-09-10T08:00:27","slug":"news20260910","status":"publish","type":"post","link":"https:\/\/microncro.com\/en\/archives\/post\/news20260910\/","title":{"rendered":"The Frontline of Theranostics \u2014 A KOL\u2019s Perspective on Challenges and Future Prospects in Japan"},"content":{"rendered":"\n


Nuclear medicine uses radioactive tracers to visualize organ and tissue function, supporting disease diagnosis and treatment. Theranostics, an approach that combines targeted diagnostic imaging and therapy, is opening new possibilities for personalized medicine.

In this edition of Micron\u2019s ViewPoint, we speak with Professor Seigo Kinuya of Kanazawa University, whose career spans clinical practice, research, education, and leadership in nuclear medicine. He reflects on his experience and explores the current landscape, key challenges, and future prospects of theranostics in Japan.

We hope you enjoy the interview and discover fresh perspectives on this evolving field.

Download the full interview below.
The Frontline of Theranostics \u2014 A KOL\u2019s Perspective on Challenges and Future Prospects in Japan<\/a><\/p>\n\n\n\n

For inquiries regarding this annnouncement,please contact us here<\/a>
<\/p>\n\n\n\n\n

\n\t
\n\t\t

Share<\/h2>\n\t\t